🇺🇸 FDA
Patent

US 11369627

Myrtle polysaccharide P1, the separation method thereof and the use in preparing hypolipidemic drugs therefor

granted A61KA61K31/715A61P

Quick answer

US patent 11369627 (Myrtle polysaccharide P1, the separation method thereof and the use in preparing hypolipidemic drugs therefor) held by South China Normal University School of Life Sciences expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
South China Normal University School of Life Sciences
Grant date
Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/715, A61P, A61P3/06